Literature DB >> 228062

New procedure for isolation of Rous sarcoma virus-specific RNA from infected cells.

P A Bromley, P F Spahr, J L Darlix.   

Abstract

The use of mercurated "strong stop" complementary DNA (complementary to the 5'-terminal 101 nucleotides of Rous sarcoma virus RNA) in the isolation of virus-specific RNA from infected chicken embryo fibroblasts is described. Strong stop Rous sarcoma virus complementary DNA was mercurated chemically, and, as a result of the low complexity of this DNA, short hybridization times (up to 15 min) and heating in the absence of formamide were found to be adequate conditions for the isolation of virus-specific RNA. The purity of the isolated RNA was demonstrated by analysis of labeled RNase T1-resistant oligonucleotides by two-dimensional polyacrylamide gel electrophoresis. The isolated RNA could be translated in the in vitro protein synthesis system derived from rabbit reticulocytes, and an analysis of polypeptides programmed by isolated RNA before and after immunoprecipitation further demonstrated both the purity of the isolated mRNA and the quantitative nature of the isolation procedure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228062      PMCID: PMC353424     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product.

Authors:  J L Darlix; P F Spahr; P A Bromley; J C Jaton
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Characterization of the genomic RNA from a Rous sarcoma virus mutant temperature sensitive for cell transformation.

Authors:  J L Darlix; M Levray; P A Bromley; P F Spahr
Journal:  Nucleic Acids Res       Date:  1979-02       Impact factor: 16.971

3.  Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication.

Authors:  E Stoll; M A Billeter; A Palmenberg; C Weissmann
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

4.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

5.  Characteristics of virus-specific RNA in avian sarcoma virus-transformed BHK-21 cells and revertants.

Authors:  C T Deng; D Stehelin; J M Bishop; H E Varmus
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

6.  Genes responsible for transformation by avian RNA tumor viruses.

Authors:  J M Coffin
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

7.  The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses.

Authors:  S R Weiss; H E Varmus; J M Bishop
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

8.  Purification of virus-specific RNA from chicken cells infected with avian sarcoma virus: identification of genome-length and subgenome-leghth viral RNAs.

Authors:  J T Parsons; P Lewis; P Dierks
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

9.  Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Authors:  W A Haseltine; A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  Extensive in vitro transcription of rous sarcoma virus RNA by avian myeloblastosis virus DNA polymerase and concurrent activation of the associated RNase H.

Authors:  J L Darlix; P A Bromley; P F Spahr
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

View more
  2 in total

1.  Massive heat-shock polypeptide synthesis in late chicken embryos: convenient system for study of protein synthesis in highly differentiated organisms.

Authors:  R Voellmy; P A Bromley
Journal:  Mol Cell Biol       Date:  1982-05       Impact factor: 4.272

2.  Purification and translation of murine mammary tumor virus mRNA's.

Authors:  J P Dudley; H E Varmus
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.